| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |